Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-2.69%
1,068.24
-29.57
-2.69%
—1,097.811,087.761,087.761,067.42——
SIXC
Communications
SIXC
Communications
SIXC
-0.89%
606.59
-5.44
-0.89%
—612.03612.03612.03606.13——
SIXE
Energy
SIXE
Energy
SIXE
+2.19%
1,247.21
+26.78
+2.19%
—1,220.431,221.991,247.601,221.99——
SIXI
Industrials
SIXI
Industrials
SIXI
-1.82%
1,727.58
-31.94
-1.82%
—1,759.521,754.311,754.311,723.60——
SIXM
Financials
SIXM
Financials
SIXM
-0.32%
629.54
-2.00
-0.32%
—631.54631.27633.99628.63——
SIXR
Staples
SIXR
Staples
SIXR
-0.42%
853.60
-3.56
-0.42%
—857.16858.91861.71852.33——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-1.56%
212.04
-3.37
-1.56%
—215.41215.41215.41211.88——
SIXT
Technology
SIXT
Technology
SIXT
-1.78%
3,549.76
-64.39
-1.78%
—3,614.153,556.243,598.363,516.86——
SIXU
Utilities
SIXU
Utilities
SIXU
-2.40%
886.49
-21.81
-2.40%
—908.30906.55906.55885.88——
SIXV
Health care
SIXV
Health care
SIXV
-1.08%
1,464.34
-16.06
-1.08%
—1,480.401,479.551,484.431,462.52——
SIXY
Discretionary
SIXY
Discretionary
SIXY
-1.84%
2,354.25
-44.12
-1.84%
—2,398.372,373.092,373.092,350.27——
Q1 2026 earnings • released • EPS miss -157.14% • Revenue miss -29.73%
See results
VLA:EPA
Valneva SE
€2.47
-3.59%
(-0.092) 1D
May 15, 5:35:17 PM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for VLA...
Open
€2.56
High
€2.60
Low
€2.47
Mkt. cap
477.60M
Avg. vol.
1.37M
Volume
676.70K
52-wk high
€5.42
52-wk low
€2.14
EPS
-€0.68
Shares outstanding
189.77M
No. of employees
674
News stories
From sources across the web
Profile
Valneva SE is a specialty vaccine company registered in Saint-Herblain, France, developing, producing and commercializing vaccines for infectious diseases. It has manufacturing sites in Livingston, Scotland; Solna, Sweden, and Vienna, Austria; with other offices in France, Canada and the United States. Wikipedia
About Valneva SE
CEOThomas Lingelbach
Employees674
Founded2013
Headquarters-
SectorBiotechnology
Websitevalneva.com
Last report
May 13, 2026
Fiscal Period
Q1 2026
EPS / Est. (EUR)
-€0.18 / -€0.07
-157.14%miss
Revenue / Est. (EUR)
30.90M / 43.98M
-29.73%miss
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in EUR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in EUR
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
48.33M
29.41M
47.69M
30.90M
Cost of goods sold
41.61M
51.19M
61.64M
26.18M
Cost of revenue
41.61M
51.19M
61.64M
-
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
19.99M
18.80M
16.54M
-
Operating expense
17.36M
15.56M
13.73M
28.42M
Total operating expenses
58.97M
66.76M
75.37M
-
Operating income
-10.64M
-37.35M
-27.68M
-23.70M
Other non operating income
-1.00K
-
-
526.00K
EBT including unusual items
-11.81M
-43.47M
-51.08M
-31.25M
EBT excluding unusual items
-11.58M
-43.70M
-51.49M
-31.25M
Income tax expense
-223.00K
882.00K
-1.06M
824.00K
Effective tax rate
1.89%
-2.03%
2.08%
-
Other operating expenses
-2.62M
-3.24M
-2.81M
-
Net income
-11.59M
-44.36M
-50.02M
-32.07M
Net profit margin
-23.97%
-150.82%
-104.89%
-103.78%
Earnings per share
-
-
-
-0.18
Interest and investment income
554.00K
808.00K
-
-
Interest expense
-5.61M
-5.67M
-24.71M
-5.09M
Net interest expenses
-5.05M
-4.86M
-24.71M
-
Depreciation and amortization charges
-
-
-
-
EBITDA
-5.23M
-31.96M
-26.96M
-
Gain or loss from assets sale
230.00K
-230.00K
432.00K
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer